Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Potassium role in the human body and clinical implications of hyperkalemia].
Binaghi G, Abrignani MG, Temporelli PL, Casula M, Maloberti A, Riccio C, Colivicchi F, Grimaldi M, Gabrielli D, Oliva F. Binaghi G, et al. Among authors: maloberti a. G Ital Cardiol (Rome). 2025 Jan;26(1):50-60. doi: 10.1714/4394.43959. G Ital Cardiol (Rome). 2025. PMID: 39714500 Review. Italian.
Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?
Maloberti A, Colombo V, Daus F, De Censi L, Abrignani MG, Temporelli PL, Binaghi G, Colivicchi F, Grimaldi M, Gabrielli D, Borghi C, Oliva F. Maloberti A, et al. Nutr Metab Cardiovasc Dis. 2024 Nov 16:103792. doi: 10.1016/j.numecd.2024.103792. Online ahead of print. Nutr Metab Cardiovasc Dis. 2024. PMID: 39674722 Free article. Review.
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry).
Gargiulo P, Marzano F, Crisci M, Marcucci R, Bruzzese D, Maloberti A, Sarullo FM, Galasso G, Indolfi C, Musumeci G, Corleto A, Calabrò P, Carugo S, Casu G, Picciolo A, Ciccone MM, Bilato C, Polimeni A, Giallauria F, Catalano A, De Luca L, Niccoli G, Venturini E, Pepe M, Montisci R, Brunetti ND, Patti G, Porto I, Margonato A, Floresta M, Muscoli S, Cameli M, Andò G, Di Lorenzo E, Berteotti M, Giannattasio C, Sarullo S, Formisano C, Di Costanzo A, Delnevo F, Varbella F, Cesaro A, Franzese M, Mancusi C, Fontanarosa S, Di Santo M, Cotticelli C, Perrone Filardi F, Paolillo S, Esposito G, Corsini A, Perrone Filardi P; CHOLINET Investigators. Gargiulo P, et al. Among authors: maloberti a. J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10318-X. doi: 10.1016/j.jacc.2024.10.106. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39665700 No abstract available.
Prescriptive Appropriateness in an Outpatient Primary and Secondary Cardiovascular Prevention Service.
Ceruti D, Tognola C, Algeri M, Shkodra A, Politi F, Bellantonio V, Gualini E, Le Van M, Campana M, Pedroli S, Tedeschi Polmonari P, Brucato F, Giannattasio C, Maloberti A. Ceruti D, et al. Among authors: maloberti a. High Blood Press Cardiovasc Prev. 2024 Dec 9. doi: 10.1007/s40292-024-00697-3. Online ahead of print. High Blood Press Cardiovasc Prev. 2024. PMID: 39648197
Role of PCSK9 Inhibitors in Venous Thromboembolism: Current Evidence and Unmet Clinical Needs.
Zuin M, Corsini A, Dalla Valle C, De Rosa C, Maloberti A, Mojoli M, Rizzo M, Ciccirillo F, Madrid A, Riccio C, Grimaldi M, Colivicchi F, Oliva F, Temporelli PL. Zuin M, et al. Among authors: maloberti a. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 15:pvae076. doi: 10.1093/ehjcvp/pvae076. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39406397
Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement.
Tognola C, Myriam Intravaia RC, Senini E, Pezzoli S, Riccio A, Gualini E, Fabbri S, Bellantonio V, Politi F, Campana M, Fucile I, Mancusi C, Golia E, Cesaro A, De Luca N, Calabrò P, Giannattasio C, Maloberti A. Tognola C, et al. Among authors: maloberti a. Nutr Metab Cardiovasc Dis. 2024 Aug 10:S0939-4753(24)00303-X. doi: 10.1016/j.numecd.2024.08.006. Online ahead of print. Nutr Metab Cardiovasc Dis. 2024. PMID: 39289142
Uric acid and metabolic syndrome: Importance of hyperuricemia cut-off.
Maloberti A, Tognola C, Garofani I, Algeri M, Shkodra A, Bellantonio V, Le Van M, Pedroli S, Campana M, Toscani G, Bombelli M, Giannattasio C. Maloberti A, et al. Int J Cardiol. 2024 Dec 15;417:132527. doi: 10.1016/j.ijcard.2024.132527. Epub 2024 Sep 5. Int J Cardiol. 2024. PMID: 39244097 Free article.
Cardiac amyloidosis red flags: What all the cardiologist have to know.
Maloberti A, Ciampi C, Politi F, Fabbri S, Musca F, Giannattasio C. Maloberti A, et al. Int J Cardiol Cardiovasc Risk Prev. 2024 Apr 27;21:200271. doi: 10.1016/j.ijcrp.2024.200271. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39118988 Free PMC article. Review.
Treatment of obesity with liraglutide in cardiovascular prevention: Case series by the "ITACARE-P Light-Heart Lab" working group.
Maranta F, Buffoli F, Giudici V, Malfatto G, Maloberti A, Maresca L, Passaretti B, Torri A, Turato R, Ambrosetti M. Maranta F, et al. Among authors: maloberti a. Int J Cardiol Cardiovasc Risk Prev. 2024 Apr 27;21:200272. doi: 10.1016/j.ijcrp.2024.200272. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39118985 Free PMC article. Review. No abstract available.
139 results